» Articles » PMID: 38993969

Non-invasive Hepatic Fat Quantification: Can Multi-echo Dixon Help?

Overview
Journal Radiol Bras
Specialty Radiology
Date 2024 Jul 12
PMID 38993969
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: To evaluate the diagnostic accuracy of multi-echo Dixon magnetic resonance imaging (MRI) in hepatic fat quantification, in comparison with that of magnetic resonance spectroscopy (MRS), on 3.0-T MRI.

Materials And Methods: Fifty-five adults with no known liver disease underwent MRI in a 3.0-T scanner for determination of the hepatic fat fraction, with two techniques: multi-echo Dixon, in a manually drawn region of interest (ROI) and in the entire liver parenchyma (automated segmentation); and MRS. The diagnostic accuracy and cutoff value for multi-echo Dixon were determined, with MRS being used as the reference standard.

Results: The mean fat fraction obtained by multi-echo Dixon in the manually drawn ROI and in the entire liver was 5.2 ± 5.8% and 6.6 ± 5.2%, respectively, whereas the mean hepatic fat fraction obtained by MRS was 5.7 ± 6.4%. A very strong positive correlation and good agreement were observed between MRS and multi-echo Dixon, for the ROI (r = 0.988, r = 0.978, < 0.001) and for the entire liver parenchyma (r = 0.960, r = 0.922, < 0.001). A moderate positive correlation was observed between the hepatic fat fraction and body mass index of the participants, regardless of the fat estimation technique employed.

Conclusion: For hepatic fat quantification, multi-echo Dixon MRI demonstrated a very strong positive correlation and good agreement with MRS (often considered the gold-standard noninvasive technique). Because multi-echo Dixon MRI is more readily available than is MRS, it can be used as a rapid tool for hepatic fat quantification, especially when the hepatic fat distribution is not homogeneous.

References
1.
Hetterich H, Bayerl C, Peters A, Heier M, Linkohr B, Meisinger C . Feasibility of a three-step magnetic resonance imaging approach for the assessment of hepatic steatosis in an asymptomatic study population. Eur Radiol. 2015; 26(6):1895-904. DOI: 10.1007/s00330-015-3966-y. View

2.
Yu E, Golshan S, Harlow K, Angeles J, Durelle J, Goyal N . Prevalence of Nonalcoholic Fatty Liver Disease in Children with Obesity. J Pediatr. 2018; 207:64-70. PMC: 6440815. DOI: 10.1016/j.jpeds.2018.11.021. View

3.
Ferraioli G, Soares Monteiro L . Ultrasound-based techniques for the diagnosis of liver steatosis. World J Gastroenterol. 2019; 25(40):6053-6062. PMC: 6824276. DOI: 10.3748/wjg.v25.i40.6053. View

4.
Rinella M, Lazarus J, Ratziu V, Francque S, Sanyal A, Kanwal F . A multisociety Delphi consensus statement on new fatty liver disease nomenclature. Ann Hepatol. 2023; 29(1):101133. DOI: 10.1016/j.aohep.2023.101133. View

5.
Bashir M, Zhong X, Nickel M, Fananapazir G, Kannengiesser S, Kiefer B . Quantification of hepatic steatosis with a multistep adaptive fitting MRI approach: prospective validation against MR spectroscopy. AJR Am J Roentgenol. 2015; 204(2):297-306. DOI: 10.2214/AJR.14.12457. View